These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 18394773)
1. Glucose metabolism and angiogenesis in granulosa cell tumors of the ovary: activation of Akt, expression of M2PK, TKTL1 and VEGF. Schmidt M; Kammerer U; Segerer S; Cramer A; Kohrenhagen N; Dietl J; Voelker HU Eur J Obstet Gynecol Reprod Biol; 2008 Jul; 139(1):72-8. PubMed ID: 18394773 [TBL] [Abstract][Full Text] [Related]
2. Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma. Huang Y; Hua K; Zhou X; Jin H; Chen X; Lu X; Yu Y; Zha X; Feng Y Cell Res; 2008 Jul; 18(7):780-91. PubMed ID: 18574502 [TBL] [Abstract][Full Text] [Related]
3. The clinicopathological and prognostic relevance of pyruvate kinase M2 and pAkt expression in breast cancer. Benesch C; Schneider C; Voelker HU; Kapp M; Caffier H; Krockenberger M; Dietl J; Kammerer U; Schmidt M Anticancer Res; 2010 May; 30(5):1689-94. PubMed ID: 20592362 [TBL] [Abstract][Full Text] [Related]
4. The reduction in pigment epithelium-derived factor is a sign of malignancy in ovarian cancer expressing low-level of vascular endothelial growth factor. Tsuchiya T; Nakahama K; Asakawa Y; Maemura T; Tanaka M; Takeda S; Morita M; Morita I Gynecol Endocrinol; 2009 Feb; 25(2):104-9. PubMed ID: 19253105 [TBL] [Abstract][Full Text] [Related]
5. Influence of dichlorodiphenylchloroethylene on vascular endothelial growth factor and insulin-like growth factor in human and rat ovarian cells. Holloway AC; Petrik JJ; Younglai EV Reprod Toxicol; 2007; 24(3-4):359-64. PubMed ID: 17574386 [TBL] [Abstract][Full Text] [Related]
6. Quantitative gene-expression of the tumor angiogenesis markers vascular endothelial growth factor, integrin alphaV and integrin beta3 in human neuroendocrine tumors. Oxboel J; Binderup T; Knigge U; Kjaer A Oncol Rep; 2009 Mar; 21(3):769-75. PubMed ID: 19212638 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical study of angiogenesis and angiogenic factors in equine granulosa cell tumours. Müller K; Ellenberger C; Hoppen HO; Schoon HA Res Vet Sci; 2012 Jun; 92(3):471-7. PubMed ID: 21492887 [TBL] [Abstract][Full Text] [Related]
8. CD56 expression in ovarian granulosa cell tumors, and its diagnostic utility and pitfalls. Ohishi Y; Kaku T; Oya M; Kobayashi H; Wake N; Tsuneyoshi M Gynecol Oncol; 2007 Oct; 107(1):30-8. PubMed ID: 17583777 [TBL] [Abstract][Full Text] [Related]
9. Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells. Mazurek S Int J Biochem Cell Biol; 2011 Jul; 43(7):969-80. PubMed ID: 20156581 [TBL] [Abstract][Full Text] [Related]
11. Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells. Eigenbrodt E; Reinacher M; Scheefers-Borchel U; Scheefers H; Friis R Crit Rev Oncog; 1992; 3(1-2):91-115. PubMed ID: 1532331 [TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor expression in ovarian cancer: a model for targeted use of novel therapies? Duncan TJ; Al-Attar A; Rolland P; Scott IV; Deen S; Liu DT; Spendlove I; Durrant LG Clin Cancer Res; 2008 May; 14(10):3030-5. PubMed ID: 18483368 [TBL] [Abstract][Full Text] [Related]
13. Characterization of the metabolic changes underlying growth factor angiogenic activation: identification of new potential therapeutic targets. Vizán P; Sánchez-Tena S; Alcarraz-Vizán G; Soler M; Messeguer R; Pujol MD; Lee WN; Cascante M Carcinogenesis; 2009 Jun; 30(6):946-52. PubMed ID: 19369582 [TBL] [Abstract][Full Text] [Related]
14. Increased staining for phosphorylated AKT and nuclear factor-kappaB p65 and their relationship with prognosis in epithelial ovarian cancer. Guo RX; Qiao YH; Zhou Y; Li LX; Shi HR; Chen KS Pathol Int; 2008 Dec; 58(12):749-56. PubMed ID: 19067848 [TBL] [Abstract][Full Text] [Related]
15. Expression of transketolase-like 1 protein (TKTL1) in human endometrial cancer. Krockenberger M; Engel JB; Schmidt M; Kohrenhagen N; Häusler SF; Dombrowski Y; Kapp M; Dietl J; Honig A Anticancer Res; 2010 May; 30(5):1653-9. PubMed ID: 20592357 [TBL] [Abstract][Full Text] [Related]
16. Tissue inhibitor of metalloproteinases-3 interacts with angiotensin II type 2 receptor and additively inhibits angiogenesis. Kang KH; Park SY; Rho SB; Lee JH Cardiovasc Res; 2008 Jul; 79(1):150-60. PubMed ID: 18344519 [TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor alpha and progesterone receptor expression in ovarian adult granulosa cell tumors and Sertoli-Leydig cell tumors. Farinola MA; Gown AM; Judson K; Ronnett BM; Barry TS; Movahedi-Lankarani S; Vang R Int J Gynecol Pathol; 2007 Oct; 26(4):375-82. PubMed ID: 17885486 [TBL] [Abstract][Full Text] [Related]
18. Expression of EBV latent antigens, mammalian target of rapamycin, and tumor suppression genes in EBV-positive smooth muscle tumors: clinical and therapeutic implications. Ong KW; Teo M; Lee V; Ong D; Lee A; Tan CS; Vathsala A; Toh HC Clin Cancer Res; 2009 Sep; 15(17):5350-8. PubMed ID: 19706821 [TBL] [Abstract][Full Text] [Related]
19. Expression of transketolase-like 1 and activation of Akt in grade IV glioblastomas compared with grades II and III astrocytic gliomas. Völker HU; Hagemann C; Coy J; Wittig R; Sommer S; Stojic J; Haubitz I; Vince GH; Kämmerer U; Monoranu CM Am J Clin Pathol; 2008 Jul; 130(1):50-7. PubMed ID: 18550470 [TBL] [Abstract][Full Text] [Related]